Isdianto Septiadi, Suwandi Sugandi, Bambang S Noegroho, Tjahjodjati Tjahjodjati, Ferry Safriadi, Safendra Siregar, Ricky Adriansjah, Kuncoro Adi, Aaron T Sihombing, Sawkar V Pramod, Ramlan Nasution, Betthy S Hernowo


Objective: The aim of the study was to detect the differences in number and the distribution of angiotensin II type-1 receptor (AT1R) in BPH, high grade PIN, and adenocarcinoma of the prostate. Material & method: A prospective study was performed in RSHS, in collaboration with the Department of Anatomical Pathology. Prostate samples were taken by TUR of the prostate, and then divided into 5 groups. They were BPH, high grade PIN, adenocarcinoma of the prostate in 3 difference grades (well, moderate, and poorly differentiated). Kidney tissue for control. Immunohistochemical staining was done to determine the angiotensin II type-1 (AT1R) receptor distribution as primary antibody used was mouse monoclonal antibody AT1 (TONI-1): sc-57036, Santa Cruz Biotechnology Inc., CA. Results: Angiotensin II type-1 receptor was found in material of BPH, high grade PIN and adenocarcinoma of the prostate. The number and distribution of the receptors were not different. Conclusion: There are no significant differences in number and distribution of angiotensin II type-1 receptor on BPH, high grade PIN, and adenocarcinoma of the prostate.


Angiotensin II; high grade PIN; adenocarcinoma of the prostate

Full Text:



Klein E, Platz E, Thompson I. Epidemiology, etiology, and prevention of prostate cancer. Campbell – Walsh Urology. 9th ed. 2007; 90: 2866-7.

Diem T, Albert G, Melissa Sourial. Identification, distribution, and expression of angiotensin II receptors in the normal human prostate. Endocrinology 2001; 142: 1349-56.

Brunner HR, Nussberger J, Waeber B. Tissue angiotensin generation and regulation. Pharmacol Ther 2001; 65: 193-213.

Matsubara H, Inada M. Molecular insights into angiotensin II type 1 and type 2 receptors: Expression, signalling and physiologic function and clinical application. Endocrinology J 1998; 45: 137-50.

Csikos T, Chung O, Unger T. Receptors and their classification: Focus on angiotensin II and the AT2 receptor. J Hum Hypertens 1998; 12: 311-8.

Maruenda J, Bhatnagar V, Lowenthal DT. Hypertension in the elderly with coexisting benign prostatic hyperplasia. Urologie 1999; 53: 7-12.

Story DF, Ziogas J. Interaction of angiotensin II with noradrenergic transmission. Trends Pharmacol Sci 1987; 8: 269-71.

Hiroji U, Hitoshi I, Yoji N, Takeshi S. Antiproliferative activity of angiotensin II receptor blocker. Molecular Cancer Ther 2005; 4: 1699-709.

Huckle WR, Earp HS. Regulation of cell proliferation and growth by angiotensin II. Prog Growth Factor Res 1994; 5: 177-94.

Harrison-Bernard LM, Navar LG, Ho MM. Immunohistochemical localization of Ang II AT1 receptor in adult rat kidney using monoclonal antibody. Am J Physiology 1998; 273: 170-7.

Van Sande ME, Scharpe, Neels HM. Distribution of angiotensin converting enzyme in human tissue. Clin Chim Acta 1995; 147: 255-60.

Yokoyama M, Takaha M, Iwata H. Angiotensin-converting enxyme in the human prostate. Clin Chim Acta 1980; 100: 253-8.


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.